Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy

Japanese Circulation Journal

Volumn 60, Issue 10, 1996, Pages 767-773

  Suwa, Michihiro ^a   Ito, Takahide ^a   Otake, Yoshiaki ^a   Moriguchi, Ayaka ^a   Hirota, Yuzo ^a   Kawamura, Keishiro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Beta blocking agents; Calcium blocking agents; Dilated cardiomyopathy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEMALE; HEART DILATATION; HEART FAILURE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BISOPROLOL; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHY, DILATED; CROSS-OVER STUDIES; DILTIAZEM; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 0029860510     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.60.767     Document Type: Article

References (15)

1. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I: Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-1036
2. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I: Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J 1980; 44: 117-133
3. Waagstein F, Caidahl K, Wallentin I, Berph Ch, Hjalmarson A: Long-term beta-blockade in dilated cardiomyopathy: effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 1989; 80: 551-563
4. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441-1446
5. CIBIS Investigators and Committees: A randomized trial of β-blockade in heart failure: The cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994; 90: 1765-1773
6. Packer M, Kessler PD, Lee WH: Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far. Circulation 1987; 75(Suppl V): V56-V64
7. The Multicenter Diltiazem Postinfarction Trial Research Group: The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988; 319: 385-392
8. Walsh RW, Porter CB, Starling M, O' Rourke RA: Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure. J Am Coll Cardiol 1984; 3: 1044-1050
9. Figulla HR, Rechenberg JV, Wiegand V, Soballa R, Kreuzer H: Beneficial effects of long-term diltiazem treatment in dilated cardiomyopathy. J Am Coll Cardiol 1989; 13: 653-658
10. Chidsey CA, Braunwald E, Morrow AG: Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med 1965; 39: 442-451
11. Murphree SS, Saffitz JE: Distribution of β-adrenergic receptors in failing human myocardium: Implication for mechanisms of down-regulation. Circulation 1989; 79: 1214-1225
12. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82: 1730-1736
13. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB: Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982; 307: 205-211
14. Woodley SL, Gilbert EM, Anderson JL, O' Connell JB, Deitchman D, Yanowitz FG, Mealey PC, Volkman K, Renlund DG, Menlove R, Bristow MR: β-Blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991; 84: 2426-2441
15. Rich S, Kaufmann E, Levy PS: The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81